erythromycin has been researched along with cefadroxil anhydrous in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (18.18) | 18.7374 |
| 1990's | 6 (27.27) | 18.2507 |
| 2000's | 5 (22.73) | 29.6817 |
| 2010's | 7 (31.82) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Green, EM; Heskel, NS; Pichotta, PJ; Siepman, NC; Stoll, RW | 1 |
| Ducroix, JP; Gaudio, F; Laurans, G; Orfila, J | 1 |
| Milatovic, D | 1 |
| Friedman, AD | 1 |
| D'Angelo, D; Esposito, JV; Furst, ML; Lefkowitz, RD; Morse, DR | 1 |
| Grahn, E; Holm, SE; Roos, K | 1 |
| Can, R; Güngör, A; Kirsaç, N; Kotiloğlu, G; Kunak, B; Nalça, M; Tuncer, AM; Yeğinaltay, T | 1 |
| Chigira, M; Maehara, S; Nagase, M; Ogimi, T; Udagawa, E | 1 |
| Trujillo, H | 1 |
| Parish, LC | 1 |
| Holm, M; Tärnvik, A | 1 |
1 review(s) available for erythromycin and cefadroxil anhydrous
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for erythromycin and cefadroxil anhydrous
| Article | Year |
|---|---|
Erythromycin versus cefadroxil in the treatment of skin infections.
Topics: Adolescent; Adult; Cefadroxil; Double-Blind Method; Erythromycin; Humans; Staphylococcal Skin Infections | 1992 |
Evaluation of cefadroxil, penicillin and erythromycin in the treatment of streptococcal tonsillopharyngitis.
Topics: Anti-Bacterial Agents; Cefadroxil; Child; Erythromycin; Humans; Penicillin V; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Tonsillitis | 1991 |
A comparison of erythromycin and cefadroxil in the prevention of flare-ups from asymptomatic teeth with pulpal necrosis and associated periapical pathosis.
Topics: Acute Disease; Adolescent; Adult; Aged; Cefadroxil; Chi-Square Distribution; Child; Dental Pulp Necrosis; Edema; Erythromycin; Female; Humans; Male; Middle Aged; Pain Measurement; Pain, Postoperative; Periapical Diseases; Premedication; Randomized Controlled Trials as Topic; Root Canal Therapy; Surveys and Questionnaires | 1990 |
Clarithromycin in the treatment of skin and skin structure infections: two multicenter clinical studies. Clarithromycin Study Group.
Topics: Cefadroxil; Clarithromycin; Double-Blind Method; Erythromycin; Humans; Single-Blind Method; Skin Diseases, Bacterial | 1993 |
17 other study(ies) available for erythromycin and cefadroxil anhydrous
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefuroxime; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; In Vitro Techniques; Moraxella catarrhalis | 1991 |
Impetigo therapy.
Topics: Anti-Bacterial Agents; Cefadroxil; Erythromycin; Fatty Acids; Humans; Impetigo; Mupirocin | 1990 |
Penicillin tolerance in beta-streptococci isolated from patients with tonsillitis.
Topics: Cefadroxil; Clindamycin; Doxycycline; Drug Tolerance; Erythromycin; Humans; Penicillin Resistance; Penicillin V; Streptococcal Infections; Streptococcus; Tonsillitis | 1987 |
[The frequency of group A beta-hemolytic Streptococcus in acute tonsillopharyngitis and therapy with cefadroxil, clavulanic acid-amoxicillin combination and erythromycin in patients unresponsive to procaine penicillin therapy].
Topics: Acute Disease; Adolescent; Anti-Bacterial Agents; Cefadroxil; Child; Child, Preschool; Drug Combinations; Erythromycin; Female; Humans; Male; Penicillin G Procaine; Penicillin Resistance; Pharyngitis; Streptococcal Infections; Streptococcus pyogenes; Sulfamethoxazole; Tonsillitis; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Sternocostoclavicular hyperostosis. A report of nineteen cases, with special reference to etiology and treatment.
Topics: Adult; Aged; Bone Diseases; Cefadroxil; Clavicle; Drug Therapy, Combination; Erythromycin; Female; Flurbiprofen; Foot Dermatoses; Hand Dermatoses; Humans; Male; Middle Aged; Radiography; Ribs; Sternum | 1986 |
Cefadroxil monohydrate versus erythromycin in paediatric patients.
Topics: Cefadroxil; Cephalexin; Child; Child, Preschool; Erythromycin; Erythromycin Estolate; Female; Humans; Infant; Male; Otitis Externa; Otitis Media; Respiratory Tract Infections | 1981 |
Hospitalization due to Pasteurella multocida-infected animal bite wounds: correlation with inadequate primary antibiotic medication.
Topics: Adolescent; Adult; Aged; Animals; Anti-Bacterial Agents; Bites and Stings; Cats; Cefadroxil; Cephalosporins; Child; Child, Preschool; Dogs; Erythromycin; Female; Floxacillin; Hospitalization; Humans; Male; Medication Errors; Middle Aged; Pasteurella Infections; Pasteurella multocida; Penicillin V; Penicillins; Retrospective Studies; Wound Infection | 2000 |